Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2011

Feb 10, 2011

34117_dirs_2011-02-10_90d94b91-6475-4179-9f92-b66d15c6056c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2011-02-08

Reporting Person: LAROUNIS GEORGE P (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-02-08 Common Stock P 280000 $0.1786 Acquired 320000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-02-08 Common Stock Purchase Warrants (Right to Buy) $0.1786 P 280000 Acquired 2016-02-08 Common stock (280000) Direct

Footnotes

F1: On February 8, 2011, Mr. Larounis purchased 280,000 shares of Common Stock, par value $0.01 and 280,000 Warrants to purchase Common Stock for an aggregate purchase price of $50,000 from CopyTele, Inc. in a private placement.